Oral Contraceptive-EMEA Market Status and Trend Report 2013-2023
Report Summary
Oral Contraceptive-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oral Contraceptive industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Oral Contraceptive 2013-2017, and development forecast 2018-2023
Main market players of Oral Contraceptive in EMEA, with company and product introduction, position in the Oral Contraceptive market
Market status and development trend of Oral Contraceptive by types and applications
Cost and profit status of Oral Contraceptive, and marketing status
Market growth drivers and challenges
The report segments the EMEA Oral Contraceptive market as:
EMEA Oral Contraceptive Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Oral Contraceptive Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Combination
Progestin Only
Others
EMEA Oral Contraceptive Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Male
Female
EMEA Oral Contraceptive Market: Players Segment Analysis (Company and Product introduction, Oral Contraceptive Sales Volume, Revenue, Price and Gross Margin):
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Oral Contraceptive-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oral Contraceptive industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Oral Contraceptive 2013-2017, and development forecast 2018-2023
Main market players of Oral Contraceptive in EMEA, with company and product introduction, position in the Oral Contraceptive market
Market status and development trend of Oral Contraceptive by types and applications
Cost and profit status of Oral Contraceptive, and marketing status
Market growth drivers and challenges
The report segments the EMEA Oral Contraceptive market as:
EMEA Oral Contraceptive Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Oral Contraceptive Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Combination
Progestin Only
Others
EMEA Oral Contraceptive Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Male
Female
EMEA Oral Contraceptive Market: Players Segment Analysis (Company and Product introduction, Oral Contraceptive Sales Volume, Revenue, Price and Gross Margin):
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ORAL CONTRACEPTIVE
1.1 Definition of Oral Contraceptive in This Report
1.2 Commercial Types of Oral Contraceptive
1.2.1 Combination
1.2.2 Progestin Only
1.2.3 Others
1.3 Downstream Application of Oral Contraceptive
1.3.1 Male
1.3.2 Female
1.4 Development History of Oral Contraceptive
1.5 Market Status and Trend of Oral Contraceptive 2013-2023
1.5.1 EMEA Oral Contraceptive Market Status and Trend 2013-2023
1.5.2 Regional Oral Contraceptive Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oral Contraceptive in EMEA 2013-2017
2.2 Consumption Market of Oral Contraceptive in EMEA by Regions
2.2.1 Consumption Volume of Oral Contraceptive in EMEA by Regions
2.2.2 Revenue of Oral Contraceptive in EMEA by Regions
2.3 Market Analysis of Oral Contraceptive in EMEA by Regions
2.3.1 Market Analysis of Oral Contraceptive in Europe 2013-2017
2.3.2 Market Analysis of Oral Contraceptive in Middle East 2013-2017
2.3.3 Market Analysis of Oral Contraceptive in Africa 2013-2017
2.4 Market Development Forecast of Oral Contraceptive in EMEA 2018-2023
2.4.1 Market Development Forecast of Oral Contraceptive in EMEA 2018-2023
2.4.2 Market Development Forecast of Oral Contraceptive by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Oral Contraceptive in EMEA by Types
3.1.2 Revenue of Oral Contraceptive in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Oral Contraceptive in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oral Contraceptive in EMEA by Downstream Industry
4.2 Demand Volume of Oral Contraceptive by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oral Contraceptive by Downstream Industry in Europe
4.2.2 Demand Volume of Oral Contraceptive by Downstream Industry in Middle East
4.2.3 Demand Volume of Oral Contraceptive by Downstream Industry in Africa
4.3 Market Forecast of Oral Contraceptive in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORAL CONTRACEPTIVE
5.1 EMEA Economy Situation and Trend Overview
5.2 Oral Contraceptive Downstream Industry Situation and Trend Overview
CHAPTER 6 ORAL CONTRACEPTIVE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Oral Contraceptive in EMEA by Major Players
6.2 Revenue of Oral Contraceptive in EMEA by Major Players
6.3 Basic Information of Oral Contraceptive by Major Players
6.3.1 Headquarters Location and Established Time of Oral Contraceptive Major Players
6.3.2 Employees and Revenue Level of Oral Contraceptive Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ORAL CONTRACEPTIVE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Pfizer, Inc.
7.1.1 Company profile
7.1.2 Representative Oral Contraceptive Product
7.1.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Pfizer, Inc.
7.2 Bayer AG
7.2.1 Company profile
7.2.2 Representative Oral Contraceptive Product
7.2.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Bayer AG
7.3 Merck & Co., Inc.
7.3.1 Company profile
7.3.2 Representative Oral Contraceptive Product
7.3.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Merck & Co., Inc.
7.4 Janssen Global Services, LLC
7.4.1 Company profile
7.4.2 Representative Oral Contraceptive Product
7.4.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Janssen Global Services, LLC
7.5 Mankind Pharma Ltd.
7.5.1 Company profile
7.5.2 Representative Oral Contraceptive Product
7.5.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Mankind Pharma Ltd.
7.6 Teva Pharmaceutical Industries Ltd
7.6.1 Company profile
7.6.2 Representative Oral Contraceptive Product
7.6.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries Ltd
7.7 Allergan, plc (Actavis)
7.7.1 Company profile
7.7.2 Representative Oral Contraceptive Product
7.7.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Allergan, plc (Actavis)
7.8 Piramal Enterprises Ltd.
7.8.1 Company profile
7.8.2 Representative Oral Contraceptive Product
7.8.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Piramal Enterprises Ltd.
7.9 Beijing Zizhu Pharm
7.9.1 Company profile
7.9.2 Representative Oral Contraceptive Product
7.9.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Beijing Zizhu Pharm
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL CONTRACEPTIVE
8.1 Industry Chain of Oral Contraceptive
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORAL CONTRACEPTIVE
9.1 Cost Structure Analysis of Oral Contraceptive
9.2 Raw Materials Cost Analysis of Oral Contraceptive
9.3 Labor Cost Analysis of Oral Contraceptive
9.4 Manufacturing Expenses Analysis of Oral Contraceptive
CHAPTER 10 MARKETING STATUS ANALYSIS OF ORAL CONTRACEPTIVE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Oral Contraceptive in This Report
1.2 Commercial Types of Oral Contraceptive
1.2.1 Combination
1.2.2 Progestin Only
1.2.3 Others
1.3 Downstream Application of Oral Contraceptive
1.3.1 Male
1.3.2 Female
1.4 Development History of Oral Contraceptive
1.5 Market Status and Trend of Oral Contraceptive 2013-2023
1.5.1 EMEA Oral Contraceptive Market Status and Trend 2013-2023
1.5.2 Regional Oral Contraceptive Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oral Contraceptive in EMEA 2013-2017
2.2 Consumption Market of Oral Contraceptive in EMEA by Regions
2.2.1 Consumption Volume of Oral Contraceptive in EMEA by Regions
2.2.2 Revenue of Oral Contraceptive in EMEA by Regions
2.3 Market Analysis of Oral Contraceptive in EMEA by Regions
2.3.1 Market Analysis of Oral Contraceptive in Europe 2013-2017
2.3.2 Market Analysis of Oral Contraceptive in Middle East 2013-2017
2.3.3 Market Analysis of Oral Contraceptive in Africa 2013-2017
2.4 Market Development Forecast of Oral Contraceptive in EMEA 2018-2023
2.4.1 Market Development Forecast of Oral Contraceptive in EMEA 2018-2023
2.4.2 Market Development Forecast of Oral Contraceptive by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Oral Contraceptive in EMEA by Types
3.1.2 Revenue of Oral Contraceptive in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Oral Contraceptive in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oral Contraceptive in EMEA by Downstream Industry
4.2 Demand Volume of Oral Contraceptive by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oral Contraceptive by Downstream Industry in Europe
4.2.2 Demand Volume of Oral Contraceptive by Downstream Industry in Middle East
4.2.3 Demand Volume of Oral Contraceptive by Downstream Industry in Africa
4.3 Market Forecast of Oral Contraceptive in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORAL CONTRACEPTIVE
5.1 EMEA Economy Situation and Trend Overview
5.2 Oral Contraceptive Downstream Industry Situation and Trend Overview
CHAPTER 6 ORAL CONTRACEPTIVE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Oral Contraceptive in EMEA by Major Players
6.2 Revenue of Oral Contraceptive in EMEA by Major Players
6.3 Basic Information of Oral Contraceptive by Major Players
6.3.1 Headquarters Location and Established Time of Oral Contraceptive Major Players
6.3.2 Employees and Revenue Level of Oral Contraceptive Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ORAL CONTRACEPTIVE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Pfizer, Inc.
7.1.1 Company profile
7.1.2 Representative Oral Contraceptive Product
7.1.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Pfizer, Inc.
7.2 Bayer AG
7.2.1 Company profile
7.2.2 Representative Oral Contraceptive Product
7.2.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Bayer AG
7.3 Merck & Co., Inc.
7.3.1 Company profile
7.3.2 Representative Oral Contraceptive Product
7.3.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Merck & Co., Inc.
7.4 Janssen Global Services, LLC
7.4.1 Company profile
7.4.2 Representative Oral Contraceptive Product
7.4.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Janssen Global Services, LLC
7.5 Mankind Pharma Ltd.
7.5.1 Company profile
7.5.2 Representative Oral Contraceptive Product
7.5.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Mankind Pharma Ltd.
7.6 Teva Pharmaceutical Industries Ltd
7.6.1 Company profile
7.6.2 Representative Oral Contraceptive Product
7.6.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries Ltd
7.7 Allergan, plc (Actavis)
7.7.1 Company profile
7.7.2 Representative Oral Contraceptive Product
7.7.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Allergan, plc (Actavis)
7.8 Piramal Enterprises Ltd.
7.8.1 Company profile
7.8.2 Representative Oral Contraceptive Product
7.8.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Piramal Enterprises Ltd.
7.9 Beijing Zizhu Pharm
7.9.1 Company profile
7.9.2 Representative Oral Contraceptive Product
7.9.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Beijing Zizhu Pharm
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL CONTRACEPTIVE
8.1 Industry Chain of Oral Contraceptive
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORAL CONTRACEPTIVE
9.1 Cost Structure Analysis of Oral Contraceptive
9.2 Raw Materials Cost Analysis of Oral Contraceptive
9.3 Labor Cost Analysis of Oral Contraceptive
9.4 Manufacturing Expenses Analysis of Oral Contraceptive
CHAPTER 10 MARKETING STATUS ANALYSIS OF ORAL CONTRACEPTIVE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
